Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: Results of a phase II study

References

• Engel J, Keer J, Eckel R, Günther B, Heiss M, Heitland W, . Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients. Eur J Surg Oncol 2005;31:512–20.
   PubMed Web of Science ®Google Scholar
• Swedish Rectal Cancer Trial (SCRT). Improved survival with preoperative radiotherapy in respectable rectal cancer. N Engl J Med 1997;336:980–7.
   PubMed Web of Science ®Google Scholar
• Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, . Preoperative radiotherapy combined with total mesorectal excision for resectable cancer. N Engl J Med 2001;345:638–46.
   PubMed Web of Science ®Google Scholar
• Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, . Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693–701.
   PubMed Web of Science ®Google Scholar
• Glimelius B. Pre- or postoperative radiotherapy in rectal cancer – more to learn? Radiother Oncol 2001;61:1–5.
   PubMed Web of Science ®Google Scholar
• Sauer R, Becker H, Hohenberg W, Rödel C, Wittekind C, Fietkau R, . German Rectal Cancer Study Group. Preoperative vs. postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–40.
   PubMed Web of Science ®Google Scholar
• Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, . Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009;92:148–63.
   PubMed Web of Science ®Google Scholar
• Allal AS, Bieri S, Bründler MA, Soravia C, Gertsch P, Bernier J, . Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: A phase I-II trial. Int J Radiat Oncol Biol Phys 2002;54:1076–81.
   PubMed Web of Science ®Google Scholar
• Bosset JF, Collette L, Calais G, Berger C, Radosevic-Jelic L, Maingon P, . EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114–23.
   PubMed Web of Science ®Google Scholar
• Gerard J, Bonnetain F, Conroy T, Bouché O, Chapet O, Closon-Dejardin MT, . Preoperatory radiotherapy with or without concurrent flourouracil in T3-4 rectal cancers: Results of the FFCD 9203. J Clin Oncol 2005;24:4620–5.
   Google Scholar
• Rodel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R. Phase I/II trial of capecitabine, oxaliplatin and radiation for rectal cancer. J Clin Oncol 2003;21: 3098–104.
   PubMed Web of Science ®Google Scholar
• Gambacorta MA, Valentini V, Coco C, Morganti AG, Smaniotto D, Miccichè F, . Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies. Int J Radiat Oncol Biol Phys 2004;60:139–48.
   PubMed Web of Science ®Google Scholar
• Avallone A, Delrio P, Guida C, Tatangelo F, Petrillo A, Marone P, . Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: A phase I-II study. Br J Cancer 2006;94:1809–15.
   PubMed Web of Science ®Google Scholar
• Valentini V, Coco C, Minsky BD, Gambacorta MA, Cosimelli M, Bellavita R, . Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: Raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:403–12.
   PubMed Web of Science ®Google Scholar
• Picardi V, Caravatta L, Morganti AG, Macchia G, Deodato F, Tambaro R, . Accelerated radiotherapy (concomitant boost) plus concurrent chemotherapy in neoadjuvant treatment of advanced rectal cancer: Preliminary results of a phase I study. Tumori 2008;(Suppl 7):8.
   Google Scholar
• Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, . AJCC Cancer Staging Manual. 6th. New York: Springer; 2002.
   Google Scholar
• Gehan EA. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chronic Dis 1961;13:346–53.
   PubMedGoogle Scholar
• Roels S, Duthoy W, Haustermans K, Penninckx F, Vandecaveye V, Boterberg T, . Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 2006;65:1129–42.
   PubMed Web of Science ®Google Scholar
• International Commission on Radiation Units and Measurements, ICRU report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Bethesda: ICRU; 1999.
   Google Scholar
• Luna-Pérez P, Trejo-Valdivia B, Labastida S, García-Alvarado S, Rodríguez DF, Delgado S. Prognostic factors in patients with locally advanced rectal adenocarcinoma treated with preoperative radiotherapy and surgery. World J Surg 1999;23:1069–74.
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, . New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205–16.
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341–6.
   PubMed Web of Science ®Google Scholar
• Colevas AD, Setser A. The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials. J Clin Oncol 2004; ASCO Annual Meeting Proceedings (Post-Meeting Edition) 14S: 6098.
   Web of Science ®Google Scholar
• Gérard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, . Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial. J Clin Oncol 2003;21:1119–24.
   PubMed Web of Science ®Google Scholar
• Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, . Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Longer analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72:99–107.
   PubMed Web of Science ®Google Scholar